Literature DB >> 27549634

Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole.

Anila Chacko1, Marissa Joseph2, Timothy Feltis3, Shaun K Morris4.   

Abstract

It is challenging to find safe, nonscarring and noninvasive treatment of facial cutaneous leishmaniasis (CL) in children. Herein, we report a child with CL from a region endemic for Leishmania tropica, whose lesion persisted after treatment with oral fluconazole but responded to topical paromomycin. Paromomycin should be considered early for treatment of Old World CL and is a well-tolerated and effective mode of therapy for facial lesions. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27549634      PMCID: PMC5062774          DOI: 10.4269/ajtmh.15-0860

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  Management of old world cutaneous leishmaniasis in refugee children.

Authors:  Joanne Crogan; Hasantha Gunasekera; Nicholas Wood; Mohamud Sheikh; David Isaacs
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

2.  Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: a randomized clinical trial.

Authors:  Maryam Emad; Fariborz Hayati; Mohammad Kazem Fallahzadeh; Mohammad Reza Namazi
Journal:  J Am Acad Dermatol       Date:  2011-03       Impact factor: 11.527

3.  Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.

Authors:  Afif Ben Salah; Nathalie Ben Messaoud; Evelyn Guedri; Amor Zaatour; Nissaf Ben Alaya; Jihene Bettaieb; Adel Gharbi; Nabil Belhadj Hamida; Aicha Boukthir; Sadok Chlif; Kidar Abdelhamid; Zaher El Ahmadi; Hechmi Louzir; Mourad Mokni; Gloria Morizot; Pierre Buffet; Philip L Smith; Karen M Kopydlowski; Mara Kreishman-Deitrick; Kirsten S Smith; Carl J Nielsen; Diane R Ullman; Jeanne A Norwood; George D Thorne; William F McCarthy; Ryan C Adams; Robert M Rice; Douglas Tang; Jonathan Berman; Janet Ransom; Alan J Magill; Max Grogl
Journal:  N Engl J Med       Date:  2013-02-07       Impact factor: 91.245

Review 4.  Leishmaniasis.

Authors:  T V Piscopo; A C Mallia
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

5.  Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major.

Authors:  Abdulrahman A Alrajhi; Elfaki A Ibrahim; Edward B De Vol; Mohammad Khairat; Rajab M Faris; James H Maguire
Journal:  N Engl J Med       Date:  2002-03-21       Impact factor: 91.245

Review 6.  Cutaneous leishmaniasis.

Authors:  Richard Reithinger; Jean-Claude Dujardin; Hechmi Louzir; Claude Pirmez; Bruce Alexander; Simon Brooker
Journal:  Lancet Infect Dis       Date:  2007-09       Impact factor: 25.071

7.  Leishmania tropica in children: a retrospective study.

Authors:  Michal Solomon; Eli Schwartz; Felix Pavlotsky; Nicole Sakka; Aviv Barzilai; Shoshana Greenberger
Journal:  J Am Acad Dermatol       Date:  2014-04-26       Impact factor: 11.527

8.  The sensitivity of Leishmania species to aminosidine.

Authors:  R A Neal; S Allen; N McCoy; P Olliaro; S L Croft
Journal:  J Antimicrob Chemother       Date:  1995-05       Impact factor: 5.790

9.  Cutaneous leishmaniasis: treatment with low-dose oral fluconazole with an excellent cosmetic result.

Authors:  Olivier Aerts; Nathalie Duchateau; Peter Willemse; Julien Lambert
Journal:  Pediatr Dermatol       Date:  2014-07-14       Impact factor: 1.588

10.  Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials.

Authors:  Dae Hyun Kim; Hye Jin Chung; Joachim Bleys; Reza F Ghohestani
Journal:  PLoS Negl Trop Dis       Date:  2009-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.